5 Common Misconceptions About Stem Cell Treatment Efficacy: StemmediCare Corrects the Facts

Stem cell therapy has garnered significant attention in the medical field in recent years, while simultaneously, exaggerated advertising and distorted information have spread rapidly. Medical claims without scientific evidence proliferate through SNS and online communities, leading to a unfortunate cycle where patients who genuinely need treatment develop false expectations. This article, based on 10 years of clinical experience by StemmediCare CEO Lee Jang-ho, uses scientific evidence to correct 5 common misconceptions surrounding stem cell therapy.

Myth 1: "Stem cell injections show immediate effects upon administration"

Many patients visiting clinics ask, "When will my pain decrease?" Particularly due to exaggerated SNS advertising—"Experience results within 48 hours," "Immediate improvement after injection"—patients develop expectations as if pain will miraculously disappear immediately after injection.

Fact: The therapeutic effects of stem cells are gradual with significant individual variation. The biological process where injected stem cells establish themselves in damaged tissue, regulate inflammation, and promote new cell regeneration requires a minimum of 4 to 8 weeks. According to patient data tracked by StemmediCare in Gangnam, Seoul, noticeable symptom improvement is observed on average at 8 to 12 weeks, with maximum effects stabilizing after 6 months.

Key Point: Stem cell therapy is not an "emergency treatment" but rather a "regenerative process."

Myth 2: "Stem cell therapy can cure all diseases"

Advertisements like "Cure cancer with stem cells," "Complete diabetes treatment with stem cells" are commonly found online. Such advertisements portray stem cells as a panacea, leading patients to mistakenly believe their conditions can also be resolved through stem cell therapy.

Fact: The effectiveness of stem cell therapy varies greatly depending on disease type, severity, patient age, and underlying conditions. The fields with the strongest scientific evidence currently are:

•Degenerative joint disease (knee, shoulder, lower back)

•Chronic musculoskeletal injuries (tendinitis, ligament tears)

•Spinal cord injuries (limited)

•Cardiovascular disease (early-stage clinical trials)

Conversely, in cases of cancer, complete neural paralysis, and genetic diseases, clinical efficacy is currently uncertain or unverified. CEO Lee Jang-ho clearly stated: "Medical professionals who recommend stem cell therapy to all patients cannot be trusted."

Key Point: Stem cell therapy has scientific evidence only for "specific stages of specific diseases."

Myth 3: "The more stem cells injected, the greater the effect"

Patients paying higher costs often ask, "Can you administer a stronger dose?" Some clinics exploit this psychology, administering 2 to 3 times the standard dose under the guise of "premium dosage" or "enhanced treatment."

Fact: The effectiveness of stem cells does not have a linear relationship with dosage. Rather:

An optimal dosage exists — Exceeding the dosage recommended by international clinical standards (ISCT), typically 2–5 million cells, increases the risk of adverse effects rather than enhanced efficacy

Cell quality matters — The viability and differentiation capacity of stem cells is a more important determining factor than cell quantity

Risks of overdose — Excessive stem cell quantities can increase abnormal inflammatory responses and tumor formation risk

StemmediCare determines customized dosage tailored to each patient's age, degree of damage, and condition.

Key Point: "Accuracy" rather than "more quantity" is the key to successful treatment.

Myth 4: "Stem cell therapy effects last a lifetime"

Some patients expect, "Once administered, won't I be good for life?" as if stem cells would permanently establish themselves in the damaged area and endlessly regenerate.

Fact: The effectiveness of stem cell therapy may gradually diminish over time. The reasons are:

Cell lifespan — Injected stem cells do not permanently survive; most naturally disappear within several months to a year

Continuous damage — Patients with arthritis or repetitive injuries may require additional treatment as new damage continues to occur

Individual variation — The older the patient and the poorer their lifestyle habits, the shorter the duration of effect maintenance

According to StemmediCare statistics in Gangnam, Seoul, 40–60% of patients consider additional treatment after 12–18 months.

Key Point: Stem cell therapy is not a "one-time cure" but rather "management-based regeneration."

Myth 5: "Stem cell therapy has no side effects whatsoever"

Beliefs such as "It comes from nature so it must be safe" and "Since they're my own cells, there's no rejection" are widespread. Such beliefs cause patients to ignore precautions after treatment.

Fact: Stem cell therapy is a medical procedure with existing side effect risks:

Injection site complications — Infection, bleeding, nerve damage (dependent on procedure technique)

Immune response — Slight rejection possibilities depending on stem cell source (bone marrow, fat, umbilical cord blood)

Tumor formation risk — Though rare, possibility of abnormal proliferation of undifferentiated stem cells

Vascular and nerve damage — Particularly nerve damage risk when injecting near the spine

What CEO Lee Jang-ho emphasizes is not "no side effects" but "side effect minimization." To achieve this, StemmediCare employs precise ultrasound-guided technology, rigorous cell verification, and post-procedure monitoring.

Key Point: "Safe stem cell therapy" means "systematically managing" risk rather than eliminating it.

After correcting misconceptions, the important question is "What are the actual effects then?" Summarizing the primary symptoms that stem cell therapy can improve:

Pain reduction — Average 30–60% reduction (not complete elimination)

Expanded joint range of motion — Average 20–40% improvement compared to pre-procedure

Enhanced daily activity capacity — Increased stair climbing, walking duration

Improved inflammation markers — MRI shows slowed cartilage damage progression

Reduced medication dependence — Possible reduction in analgesic consumption

| Treatment | Effect Onset | Duration | Side Effect Risk | Suitable Symptoms |
|-----------|--------------|----------|------------------|-------------------|
| Stem Cell Therapy | 8–12 weeks | 12–24 months | Low to moderate | Early to moderate arthritis, chronic pain |
| Steroid Injection | Within days | 3–6 months | High | Acute inflammation, short-term relief |
| Surgery (Arthroscopy) | Immediate (partial) | Long-term | Moderate to high | Severe damage, tears |
| Physical Therapy | Several weeks | Requires continuous effort | Low | Mild pain |

Q1: How does stem cell therapy differ from PRP (Platelet-Rich Plasma) therapy?

A: PRP involves injecting growth factors extracted from one's own blood, offering lower cost and simpler procedures. However, its effects are more limited than stem cells, particularly insufficient for severe tissue damage. Stem cells excel in tissue regeneration capacity itself but require more complex cultivation processes.

Q2: Is rehabilitation necessary after stem cell therapy?

A: It is essential. StemmediCare recommends 4 weeks of rest followed by 8 weeks of rehabilitation exercises post-treatment. Engaging in high-intensity activities too quickly can halve the effects. In other words, post-treatment management determines efficacy more than the stem cell injection itself.

Q3: Can elderly patients (70s and older) receive stem cell therapy?

A: It is possible, but treatment expectations must be lowered. The older the patient, the decreased differentiation capacity of stem cells and slower recovery speed. For patients in their 70s, StemmediCare conducts pre-treatment blood tests and bone density evaluation to determine suitability.

Stem cell therapy is undoubtedly a groundbreaking medical technology. However, it is not a "miracle cure." For patients suffering from arthritis, chronic pain, and chronic inflammation, it provides an evidence-based treatment option "before the final resort" and buys time to delay surgery.

StemmediCare does not promise "rapid results"; instead, it provides "accurate diagnosis" and "transparent prognosis". The essence of CEO Lee Jang-ho's 10 years of accumulated clinical experience is "setting patient expectations correctly." It is necessary to avoid the temptation of exaggerated advertising and choose treatment based on scientific fact.

Honest consultation regarding stem cell treatment efficacy is available at StemmediCare. For further inquiries, contact 02-547-1030 or stemmedicare@stemmedicare.com.

---

📍 Learn More About StemmediCare

•🌐 Website: http://www.stemmedicare.com/en/

---

#StemCellTherapy #StemmediCare #StemCellEffects #MythBusting #GangnamStemCell #ArthritisJointtTreatment #StemCellInjection #EvidenceBasedTreatment #jaiwshim_tester #MedicalMisunderstandings